Skip to content

Evaluations of Tear Protein Markers in Dry Eye Disease with Different Expression Level of LT-alpha

Evaluations of Tear Protein Markers in Dry Eye Disease with Different Expression Level of LT-alpha

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029423
Enrollment
Unknown
Registered
2020-01-31
Start date
2019-01-04
Completion date
Unknown
Last updated
2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dry eye

Interventions

Health population:Nil

Sponsors

ZhuJiang Hospital of Southern Medicine University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for the control group subjects were an OSDI score 7 s, and Schirmer I test > 7 mm. All dry eye patients had experienced symptoms of dry eyes for more than one month and had an OSDI score > 12. Inclusion criteria in the dry eye group included either TBUT <=3 s, Schirmer <=5 mm/5 min, 3 s < TBUT <=10 s and positive fluorescein staining, or 5 mm/5 min < Schirmer <=10 mm/5 min and positive fluorescein staining.

Exclusion criteria

Exclusion criteria: 1) had active ocular infection or inflammation such as active allergic conjunctivitis, active trachoma, endophthalmitis, etc.; 2) had inflammation of the eyelid or the skin surrounding the eye, such as anterior blepharitis, etc.; 3) had eyelid abnormalities, such as eyelid varus, ectropion, eyelid tumor, eyelid insufficiency, severe trichiasis, severe ptosis, etc.; 4) had previous severe corneal damage, such as corneal chemical injuries, corneal dystrophy, etc.; 5) had other systemic diseases, such as Stevens-Johnson syndrome, graft versus host disease, vitamin A deficiency, Wegener's granulomatosis, Sjogrens syndrome, etc.; 6) had an allergy to sodium fluorescein; 7) used anti-inflammatory eye drops within one week prior to examination or artificial tears on the day of examination; 8) had a history of previous?ocular surgery within 3 months of examination.

Design outcomes

Primary

MeasureTime frame
LT-alpha;

Countries

China

Contacts

Public ContactXiaohe Lu

Department of Ophthalmology, Zhujiang Hospital, Southern Medical University

luxh63@163.com+86 15002000613

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026